DNTH vs VMC · rev $6.2M vs P/E 35, rev $7.42B
Dianthus Therapeutics Inc. (DNTH) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
DNTH currently screens at market cap $4.40B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the DNTH and VMC stock pages for the full models.
Not investment advice.